nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical Universitynefr-23Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESКлинико-патогенетические аспекты повреждения почек при ожирении (обзор литературы)Clinical and paphogenical aspects of kidney damage in obesity (review)ВялковаА. А.VyalkovaA. A.k_pediatry@mail.ruЛебедеваЕ. Н.LebedevaE. N.noemail@neicon.ruКрасиковС. И.KrasikovS. I.noemail@neicon.ruЗоринИ. В.ZorinI. V.noemail@neicon.ruКулагинаЕ. П.KulaginaE. P.noemail@neicon.ruНиколаеваС. Н.NikolaevaS. N.noemail@neicon.ruГосударственное бюджетное образовательное учреждение высшего профессионального образования «Оренбургская государственная медицинская академия» Министерства здравоохранения Российской ФедерацииRussian Federation2014010520141832433Copyright © Вялкова А.А., Лебедева Е.Н., Красиков С.И., Зорин И.В., Кулагина Е.П., Николаева С.Н., 20142014Вялкова А.А., Лебедева Е.Н., Красиков С.И., Зорин И.В., Кулагина Е.П., Николаева С.Н.Vyalkova A.A., Lebedeva E.N., Krasikov S.I., Zorin I.V., Kulagina E.P., Nikolaeva S.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/23

Ожирение является одной из актуальных медико-социальных проблем современного общества. Быстрый рост числа лиц, страдающих избыточной массой тела, определяет актуальность этой проблемы. Ожирение приводит к прогрессивному повреждению почек через множество механизмов. Использование ранних биомаркеров патологии почек при ожирении с оценкой уровня показателей липидного, углеводного обмена, инсулинорезистентности, сывороточного лептина и адипонектина является перспективным для диагностики ренального поражения при ожирении у детей.

Obesity is one of actual medico-social problems of modern society. Rapid growth of the persons suffering from excess mass of a body, defines relevance of this problem. Obesity leads to progressive injury of kidneys through a set of mechanisms. Use of early biomarkers of pathology of kidneys at obesity with an assessment of level of indicators of a lipid, carbohydrate exchange, insulin resistance, serum leptin and adiponectin are perspective for diagnostics of renal defeat at obesity in children.

ожирениепочкилептинадипонектинфактор некроза опухоли-альфаренин-ангиотензиновая системавнутриклубочковая гипертензияподоцитobesitykidneyleptinadiponectintumor necrosis factor - alpharenin-angiotensin systeminteraglomerulus hypertensionpodocyteReferencesБутрова СА, Дзгоева ФХ. Висцеральное ожирение -ключевое звено метаболического синдрома. Ожирение и метаболизм 2004; (1): 10-16 [Butrova SA, Dzgoeva FH. Visceral'noe ozhirenie - kljuchevoe zveno metabolicheskogo sindroma. Ozhirenie i metabolizm 2004; (1): 10-16]Бутрова СА, Дзгоева ФХ. Висцеральное ожирение -ключевое звено метаболического синдрома. Ожирение и метаболизм 2004; (1): 10-16 [Butrova SA, Dzgoeva FH. Visceral'noe ozhirenie - kljuchevoe zveno metabolicheskogo sindroma. Ozhirenie i metabolizm 2004; (1): 10-16]Вялкова АА, Николаева СН, Лебедева ЕН и др. Характеристика липидного обмена при ожирении у детей с нефропатиями. Материалы III научно-практическая конференция «Педиатрия и детская хирургия в Приволжском федеральном округе». Казань, 2006;107-108 [Vjalkova AA, Nikolaeva SN, Lebedeva EN i dr. Harakteristika lipidnogo obmena pri ozhirenii u detej s nefropatijami. Materialy III nauchno-prakticheskaja konferencija «Pediatrija i detskaja hirurgija v Privolzhskom federal’nom okruge». Kazan’, 2006; 107-108]Вялкова АА, Николаева СН, Лебедева ЕН и др. Характеристика липидного обмена при ожирении у детей с нефропатиями. Материалы III научно-практическая конференция «Педиатрия и детская хирургия в Приволжском федеральном округе». Казань, 2006;107-108 [Vjalkova AA, Nikolaeva SN, Lebedeva EN i dr. Harakteristika lipidnogo obmena pri ozhirenii u detej s nefropatijami. Materialy III nauchno-prakticheskaja konferencija «Pediatrija i detskaja hirurgija v Privolzhskom federal’nom okruge». Kazan’, 2006; 107-108]Гинзбург ММ, Козупица ГС. Значение распределения жира при ожирении Пробл эндокр 1996; 42(3): 42-46 [Ginzburg MM, Kozupica GS. Znachenie raspredelenija zhira pri ozhirenii Probl jendokr 1996; 42(3): 42-46]Гинзбург ММ, Козупица ГС. Значение распределения жира при ожирении Пробл эндокр 1996; 42(3): 42-46 [Ginzburg MM, Kozupica GS. Znachenie raspredelenija zhira pri ozhirenii Probl jendokr 1996; 42(3): 42-46]Дедов ИИ, Мельниченко ГА, Романцова ТИ. Патогенетические аспекты ожирения. Ожирение и метаболизм 2004; (1): 3-9 [Dedov II, Mel’nichenko GA, Romancova TI. Patogeneticheskie aspekty ozhirenija. Ozhirenie i metabolizm 2004; (1): 3-9]Дедов ИИ, Мельниченко ГА, Романцова ТИ. Патогенетические аспекты ожирения. Ожирение и метаболизм 2004; (1): 3-9 [Dedov II, Mel’nichenko GA, Romancova TI. Patogeneticheskie aspekty ozhirenija. Ozhirenie i metabolizm 2004; (1): 3-9]Кутырина И., Краснова Е., Федорова Е., Фомин В. Поражение почек при ожирении: клинические, патогенетические и терапевтические аспекты. Врач 2005; (6):6-9 [Kutyrina I., Krasnova E., Fedorova E., Fomin V. Porazhenie pochek pri ozhirenii: klinicheskie, patogeneticheskie i terapevticheskie aspekty. Vrach 2005; (6):6-9]Кутырина И., Краснова Е., Федорова Е., Фомин В. Поражение почек при ожирении: клинические, патогенетические и терапевтические аспекты. Врач 2005; (6):6-9 [Kutyrina I., Krasnova E., Fedorova E., Fomin V. Porazhenie pochek pri ozhirenii: klinicheskie, patogeneticheskie i terapevticheskie aspekty. Vrach 2005; (6):6-9]Ogden CL , Yanovski SZ, Carroll MD, Flegal KM The epidemiology of obesity. Gastroenterology 2007; 132: 2087-2102Ogden CL , Yanovski SZ, Carroll MD, Flegal KM The epidemiology of obesity. Gastroenterology 2007; 132: 2087-2102Мухин НА, Балкаров ИМ, Моисеев СВ и др. Хронические прогрессирующие нефропатии и образ жизни современного человека Тер арх 2004; (9): 5-11 [Muhin NA, Balkarov IM, Moiseev SV i dr. Hronicheskie progressirujushhie nefropatii i obraz zhizni sovremennogo cheloveka Ter arh 2004; (9): 5-11]Мухин НА, Балкаров ИМ, Моисеев СВ и др. Хронические прогрессирующие нефропатии и образ жизни современного человека Тер арх 2004; (9): 5-11 [Muhin NA, Balkarov IM, Moiseev SV i dr. Hronicheskie progressirujushhie nefropatii i obraz zhizni sovremennogo cheloveka Ter arh 2004; (9): 5-11]Мухин НА, Шоничев ДГ, Балкаров ИМ и др. Формирование артериальной гипертонии при уратном тубулоинтерстициальном поражении почек Тер. арх 1999; (6): 12-24 [Muhin NA, Shonichev DG, Balkarov IM i dr. Formirovanie arterial‘noj gipertonii pri uratnom tubulointersticial‘nom porazhenii pochek Ter. arh 1999; (6): 12-24]Мухин НА, Шоничев ДГ, Балкаров ИМ и др. Формирование артериальной гипертонии при уратном тубулоинтерстициальном поражении почек Тер. арх 1999; (6): 12-24 [Muhin NA, Shonichev DG, Balkarov IM i dr. Formirovanie arterial‘noj gipertonii pri uratnom tubulointersticial‘nom porazhenii pochek Ter. arh 1999; (6): 12-24]Kambham N, Markowitz G, Valeri A et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 2001;59: 1498-1509Kambham N, Markowitz G, Valeri A et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 2001;59: 1498-1509Николаева СН, Лебедева ЕН, Вялкова АА и др. Клиническая оценка уровня лептина и инсулина в крови у детей с ожирением. Совр вопросы педиатрии 2007; (5):485-486 [Nikolaeva SN, Lebedeva EN, Vyalkova AA i dr. Klinicheskaja ocenka urovnja leptina i insulina v krovi u detej s ozhireniem. Sovr voprosy pediatrii 2007; (5):485-486]Николаева СН, Лебедева ЕН, Вялкова АА и др. Клиническая оценка уровня лептина и инсулина в крови у детей с ожирением. Совр вопросы педиатрии 2007; (5):485-486 [Nikolaeva SN, Lebedeva EN, Vyalkova AA i dr. Klinicheskaja ocenka urovnja leptina i insulina v krovi u detej s ozhireniem. Sovr voprosy pediatrii 2007; (5):485-486]Мухин НА, Арутюнов ГП, Фомин ВВ. Альбуминурия - маркер поражения почек и риска сердечно-сосудистых осложнений Клин нефр 2009;(1): 5-10 [ Muhin NA, Arutjunov GP, Fomin VV. Al’buminurija - marker porazhenija pochek i riska serdechno-sosudistyh oslozhnenij Klin nefr 2009;(1): 5-10]Мухин НА, Арутюнов ГП, Фомин ВВ. Альбуминурия - маркер поражения почек и риска сердечно-сосудистых осложнений Клин нефр 2009;(1): 5-10 [ Muhin NA, Arutjunov GP, Fomin VV. Al’buminurija - marker porazhenija pochek i riska serdechno-sosudistyh oslozhnenij Klin nefr 2009;(1): 5-10]Сигитова ОН, Бикмухамметова ЭИ, Надеева РА. Микроальбуминемия - диагностическое и прогностическое значение при артериальной гипертонии. Арт гипертенз 2009;15(6):627-632 [Sigitova ON, Bikmuhammetova JeI, Nadeeva RA. Mikroal’buminemija - diagnosticheskoe i prognosticheskoe znachenie pri arterial’noj gipertonii. Art gipertenz 2009;15(6):627-632]Сигитова ОН, Бикмухамметова ЭИ, Надеева РА. Микроальбуминемия - диагностическое и прогностическое значение при артериальной гипертонии. Арт гипертенз 2009;15(6):627-632 [Sigitova ON, Bikmuhammetova JeI, Nadeeva RA. Mikroal’buminemija - diagnosticheskoe i prognosticheskoe znachenie pri arterial’noj gipertonii. Art gipertenz 2009;15(6):627-632]Papafragkaki DK, Tolis G. Obesity and renal disease: A possible role of leptin. Hormones 2005; 4(2):90-95Papafragkaki DK, Tolis G. Obesity and renal disease: A possible role of leptin. Hormones 2005; 4(2):90-95Сагинова ЕА, Фомин ВВ, Моисеев СВ, Лебедева МВ. Поражения почек при ожирении. Тер арх 2007;(5):88-94 [Saginova EA, Fomin VV, Moiseev SV, Lebedeva MV. Porazhenija pochek pri ozhirenii. Ter arh 2007;(5):88-94 ]Сагинова ЕА, Фомин ВВ, Моисеев СВ, Лебедева МВ. Поражения почек при ожирении. Тер арх 2007;(5):88-94 [Saginova EA, Fomin VV, Moiseev SV, Lebedeva MV. Porazhenija pochek pri ozhirenii. Ter arh 2007;(5):88-94 ]Федорова ЕЮ, Кутырина ИМ. Механизмы прогрессирования поражения почек при ожирении. Нефрология и диализ 2006;(2):3-12 [Fedorova EJu, Kutyrina IM. Mehanizmy progressirovanija porazhenija pochek pri ozhirenii. Nefrologija i dializ 2006;(2):3-12]Федорова ЕЮ, Кутырина ИМ. Механизмы прогрессирования поражения почек при ожирении. Нефрология и диализ 2006;(2):3-12 [Fedorova EJu, Kutyrina IM. Mehanizmy progressirovanija porazhenija pochek pri ozhirenii. Nefrologija i dializ 2006;(2):3-12]Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013 Jan; 33(1):14-22.Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013 Jan; 33(1):14-22.Praga M, Hernаndez E, Morales E. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant2001;15: 1790-1798Praga M, Hernаndez E, Morales E. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant2001;15: 1790-1798Meier-Krieshce HU, Vaghela M, Thambuganipalle R. The effect of body index on long-trem renal allograft survival.Transplan-tation1999;68: 1294-1297Meier-Krieshce HU, Vaghela M, Thambuganipalle R. The effect of body index on long-trem renal allograft survival.Transplan-tation1999;68: 1294-1297Ahima RS. Linking adiponectin to proteinuria. JCI 2008; 118(2): 1619-1622Ahima RS. Linking adiponectin to proteinuria. JCI 2008; 118(2): 1619-1622Coresh J. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298:2038-2047Coresh J. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298:2038-2047Kramer H. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am. J. Kidney Dis. 2005; (46):587-594Kramer H. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am. J. Kidney Dis. 2005; (46):587-594Villarreal D, Reams G, Freeman RH, Taraben A. Renal effects of leptin in normotensive, hypertensive and obese rats. Am J Physiol 1998; 275: 2056-2060Villarreal D, Reams G, Freeman RH, Taraben A. Renal effects of leptin in normotensive, hypertensive and obese rats. Am J Physiol 1998; 275: 2056-2060Kohan DE. Endothelins in the normal and diseased kidney. Am. J Kidney Dis 1996; 1: 2-26Kohan DE. Endothelins in the normal and diseased kidney. Am. J Kidney Dis 1996; 1: 2-26Adamczak M, Wiecek A. The adipose tissue as an endocrine organ. Semin Nephrol. 2013 Jan; 33(1):2-13.Adamczak M, Wiecek A. The adipose tissue as an endocrine organ. Semin Nephrol. 2013 Jan; 33(1):2-13.Saxena AK , Chopra R. Renal risk of an emerging epidemic of obesity: the role of adipocyte-derived factors. Nephrol Dial Transplant 2004; 33: 11-20Saxena AK , Chopra R. Renal risk of an emerging epidemic of obesity: the role of adipocyte-derived factors. Nephrol Dial Transplant 2004; 33: 11-20van Stijn CM, Kim J, Barish GD. Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS One. 2014 Jan 22; 9 (1):e86404.van Stijn CM, Kim J, Barish GD. Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS One. 2014 Jan 22; 9 (1):e86404.Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis 2002;39: 1-11Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis 2002;39: 1-11Wolf G. Obesity and Renal Disease: Introduction. Semin Nephrol. 2013 Jan; 33(1):1.Wolf G. Obesity and Renal Disease: Introduction. Semin Nephrol. 2013 Jan; 33(1):1.Han DC, Isono M, Chen S. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 2001; 59:1315-1323Han DC, Isono M, Chen S. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 2001; 59:1315-1323Hong SW, Isono M, Chen S et al. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/ db mouse.Am J Pathol 2001;158: 1653-1663Hong SW, Isono M, Chen S et al. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/ db mouse.Am J Pathol 2001;158: 1653-1663Allessi MC, Peiretti F, Morange P. et al. Production of plasminogen activator inghibitor-1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes1997; 46: 860-867Allessi MC, Peiretti F, Morange P. et al. Production of plasminogen activator inghibitor-1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes1997; 46: 860-867Engeli S, Negel R, Sharma AM. Pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35: 1270- 1276Engeli S, Negel R, Sharma AM. Pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35: 1270- 1276Rüster C, Wolf G. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin Nephrol. 2013 Jan; 33(1):44-53Rüster C, Wolf G. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin Nephrol. 2013 Jan; 33(1):44-53Baud L, Fouqueray B, Amrani PC. Tumor necrosis factor alpha and mesangial cells Kidney Int 1992; 41: 600-603Baud L, Fouqueray B, Amrani PC. Tumor necrosis factor alpha and mesangial cells Kidney Int 1992; 41: 600-603Stenvinkel P. Leptin and its clinical implications in chronic renal failure Miner Electrolyte Metab 1999;25: 298-302Stenvinkel P. Leptin and its clinical implications in chronic renal failure Miner Electrolyte Metab 1999;25: 298-302Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome.J. Am. Soc. Nephrol. 2006;17(4, 2):S81-S85Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome.J. Am. Soc. Nephrol. 2006;17(4, 2):S81-S85Sharma K, Considini RV, Beckie M. et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Intern 1997; 51:1980-1985Sharma K, Considini RV, Beckie M. et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Intern 1997; 51:1980-1985Nasrallah MP, Ziyadeh FN. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin Nephrol. 2013 Jan; 33(1):54-65.Nasrallah MP, Ziyadeh FN. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin Nephrol. 2013 Jan; 33(1):54-65.Pistrosch F. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 2005; 54:2206-2211Pistrosch F. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 2005; 54:2206-2211Miyazaki Y Cersosimo E, Triplitt C, DeFronzo RA. Rosigli-tazone decreases albuminuria in type 2 diabetic patients. Kidney Int 2007;72:1367-1373Miyazaki Y Cersosimo E, Triplitt C, DeFronzo RA. Rosigli-tazone decreases albuminuria in type 2 diabetic patients. Kidney Int 2007;72:1367-1373Pajvani UB Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 2004;279:12152-12162Pajvani UB Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 2004;279:12152-12162Bonnet F, Deprele C, Sassolas A. et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA-nephritis.Am J Kidney Dis 2001; 37: 720-727Bonnet F, Deprele C, Sassolas A. et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA-nephritis.Am J Kidney Dis 2001; 37: 720-727Siddiqi FS, Advani A. Endothelial-Podocyte Crosstalk: The Missing Link Between Endothelial Dysfunction and Albuminuria in Diabetes. Diabetes 2013;.62 (11): 3647-3655Siddiqi FS, Advani A. Endothelial-Podocyte Crosstalk: The Missing Link Between Endothelial Dysfunction and Albuminuria in Diabetes. Diabetes 2013;.62 (11): 3647-3655Lee MJ. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 2007;292:F617-F627Lee MJ. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 2007;292:F617-F627Henegar J, Bigler S, Henegar L. et al. Functional and structural changes in the kidney in the early stages of obesity. Am J Soc Nephrol 2001;12: 1211-1217Henegar J, Bigler S, Henegar L. et al. Functional and structural changes in the kidney in the early stages of obesity. Am J Soc Nephrol 2001;12: 1211-1217Sharma K, McCue P, Dunn S. Diabetic kidney disease in the db/db mouse. Am J Renal Physiol 2003; 284: 1138-1144Sharma K, McCue P, Dunn S. Diabetic kidney disease in the db/db mouse. Am J Renal Physiol 2003; 284: 1138-1144Verani RR, Grone EF. The role of lipids in nephrosclerosis and glomerulosclerosis Atherosclerosis 1994; 107: 1-13Verani RR, Grone EF. The role of lipids in nephrosclerosis and glomerulosclerosis Atherosclerosis 1994; 107: 1-13Sharma K. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 2008; 118:1645-1656Sharma K. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 2008; 118:1645-1656Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int 2009;76:145-148Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int 2009;76:145-148Kadowaki T. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006;116:1784-1792Kadowaki T. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006;116:1784-1792Nawrocki AR. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 2006; 281:2654-2660Nawrocki AR. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 2006; 281:2654-2660Yamauchi T, Nio Y Maki T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med.2007;13:332-339Yamauchi T, Nio Y Maki T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med.2007;13:332-339Ohashi K. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 2007; 27:1910-1917Ohashi K. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 2007; 27:1910-1917Ouedraogo R, Gong X Bercins B. et al. Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 2007;117:1718-1726Ouedraogo R, Gong X Bercins B. et al. Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 2007;117:1718-1726Yano Y Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes.J Clin Hypertens (Greenwich) 2007; 9:775-782Yano Y Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes.J Clin Hypertens (Greenwich) 2007; 9:775-782Looker HC. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 2004; 89:4010-4017Looker HC. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 2004; 89:4010-4017Dengel DR, Glodberg AP, Mayuga RS. et al. Insulin resistance, elevated glomerular filtration fraction and renal injury. Hypertension 1996; 28:127-132Dengel DR, Glodberg AP, Mayuga RS. et al. Insulin resistance, elevated glomerular filtration fraction and renal injury. Hypertension 1996; 28:127-132Наточин ЮВ. Нефрология и фундаментальная наука. Нефрология 2012; 16: 9-21 [NatochinYuV. Nephrologija i fundamental’naja nauka. Nephrologija 2012; 16: 9-21]Наточин ЮВ. Нефрология и фундаментальная наука. Нефрология 2012; 16: 9-21 [NatochinYuV. Nephrologija i fundamental’naja nauka. Nephrologija 2012; 16: 9-21]Смирнов АВ, Шилов ЕМ, Добронравов ВА. Национальные Рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология 2012; 16: 89-115 [Smirnov AV, Shilov EM, Dobronravov VA. National’nye Recommendacii. Chroniches-kaja bolezn’ pochek: osnovnye principy screninga, diagnostiki, profilaktiki i podhody k lecheniju. Nephrologija 2012; 16: 89-115]Смирнов АВ, Шилов ЕМ, Добронравов ВА. Национальные Рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология 2012; 16: 89-115 [Smirnov AV, Shilov EM, Dobronravov VA. National’nye Recommendacii. Chroniches-kaja bolezn’ pochek: osnovnye principy screninga, diagnostiki, profilaktiki i podhody k lecheniju. Nephrologija 2012; 16: 89-115]Wiecek A, Kokot F, Chudek J , Adamczak M. The adipose tissue - a novel endocrine organ of interest to the nephrologists. Nephrol Dial Transplant 2002; 17: 191-195Wiecek A, Kokot F, Chudek J , Adamczak M. The adipose tissue - a novel endocrine organ of interest to the nephrologists. Nephrol Dial Transplant 2002; 17: 191-195Risheng Y, Scherer PE. Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab 2013; 2(3): 133-141Risheng Y, Scherer PE. Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab 2013; 2(3): 133-141Stenvinkel P.Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation. Journal of Renal Nutrition.2011; 21(1):82-86Stenvinkel P.Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation. Journal of Renal Nutrition.2011; 21(1):82-86Park SH, Carrero JJ, Lindholm B, Stenvinkel P. Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin. Clin Nephrol. 2009 Aug; 72(2):87-96.Park SH, Carrero JJ, Lindholm B, Stenvinkel P. Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin. Clin Nephrol. 2009 Aug; 72(2):87-96.Jeon WS, Park JW, Lee N et al. Urinary adiponectin concentration is positively associated with micro- and macrovascular complications. Cardiovasc Diabet 2013; 12:137Jeon WS, Park JW, Lee N et al. Urinary adiponectin concentration is positively associated with micro- and macrovascular complications. Cardiovasc Diabet 2013; 12:137

The authors declare that there are no conflicts of interest present.